Autopsy report · NCT01435993
Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis
Cause of deathNo reason given
Life of this trial
- Ran for about 4 months before it stopped.
- 3 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- GlaxoSmithKline
- Sponsor type
- Industry
- Conditions
- Multiple Sclerosis, Relapsing-Remitting
- Interventions
- GSK1223249; Saline placebo
- Participants
- 3
- Sites
- 2
- Countries
- Italy, Norway
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.